Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... Two pediatric patients in Pennsylvania hospitals received overdoses of the drug Tamiflu to treat their flu symptoms because of unawareness among staff as to the concentration ...
2009 NOV 16 ... Community pharmacists have stepped up to meet the shortage of Tamiflu by compounding doses for children suffering from the H1N1 flu virus, but they are ...
Subject: National Community Pharmacists Association
2009 NOV 1 ... after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir), which may pose risks to patients. One of the orders, which ...
2009 NOV 2 ... approved by the FDA for treatment and prophylaxis of the 2009 H1N1 influenza virus - Tamiflu (oseltamivir phosphate) and Relenza (zanamivir)....
2009 NOV 2 ... million for the third quarter of 2008. This increase was driven primarily by higher Tamiflu® (oseltamivir phosphate) royalties from F. Hoffmann-La Roche Ltd of $113.5 million ...
2009 NOV 2 ... As a regional coordinating hospital (RCH), Grady was also charged with distributing Tamiflu antiviral flu medicine. "As a RCH however, we were heavily impacted by the first wave ...
2009 NOV 16 ... up to 30,000 treatment courses with each manufacturer over two years. Roche manufactures Tamiflu; GlaxoSmithKline, Relenza, and BioCryst manufactures Peramivir. Because ...
Subject: U.S. Department of Health and Human Services
2009 NOV 9 ... a compound, IkT-041, comparable in activity to viral neuraminidase inhibitors (e.g. Tamiflu, Relenza), but one that is far less likely to stimulate resistance. IkT-041 has ...
2009 NOV 3 ... cases, as well as the efficacy of price controls imposed on a range of medicines from Tamiflu (oseltamivir) to certain paracetamol formulations. Keywords: , Health, ...
2009 NOV 23 ... be of a particular importance as there is increasing prevalence of drug resistance to Tamiflu=AE, and the other NAI on the market, Relenza=AE, is contraindicated for this ...
2009 NOV 16 ... of influenza and parainfluenza viruses. Unlike neuraminidase inhibitors (NAI), e.g. Tamiflu=AE (oseltamivir), as well as vaccines, which target the influenza virus ("pathogen ...
2009 OCT 19 ... and other flu-related items. Stores also are stocked with the prescription medications Tamiflu and Relenza for those patients whose doctor has recommended they take one of these ...
2009 NOV 2 ... 36% higher than the prior week. Over 502,000 prescriptions were filled for Tamiflu in the week ending Oct. 16, up 37% from just over 367,000 the week before. Prescriptions ...
2009 NOV 9 ... two weeks have been significant. Over 640,000 prescriptions were filled for Tamiflu in the week ending Oct. 23, up more than 28% from just over 502,000 the week before. ...
2009 OCT 19 ... City, and examines the extensive stockpiling of vaccines and antiviral drugs (such as Tamiflu and Relenza) and their widespread distribution for preventive use at the onset of a ...
2009 NOV 16 ... it is and whether or not it may be resistant to oseltamivir (sold under the brand name Tamiflu®; Roche), the primary anti-viral drug on the market to treat H1N1. As ...
Subject: The Translational Genomics Research Institute
2009 NOV 16 ... Diseases. In laboratory testing, the triple combination of oseltamivir (Tamiflu), amantadine (Symmetrel) and ribavirin showed a significant capacity to stop flu-virus ...
2009 NOV 1 ... Walmart and Sam's Club pharmacies nationwide will address the national shortage of Tamiflu=AE oral suspension by converting the capsule to liquid form. The FDA-approved process, ...
